SCHEMBL30262245

SCHEMBL30262245

CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ MC4R P32245 1/20 0.62
▸ RAMP3 O60896 1/20 0.62
▸ CALCR P30988 1/20 0.62
▸ F2 P00734 4/20 0.62
▸ C5AR1 P21730 1/20 0.61
▸ NMUR2 Q9GZQ4 3/20 0.60
▸ NMUR1 Q9HB89 3/20 0.60
▸ NPY2R P49146 7/20 0.59
▸ NPY4R P50391 7/20 0.59
▸ NPY5R Q15761 7/20 0.59
▸ NPY1R P25929 5/20 0.59
▸ APLNR P35414 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29362632 0.91 APLNR (0.61) MC4RRAMP3CALCRF2C5AR1
SCHEMBL30436896 0.90 CALCR (0.68) MC4RRAMP3CALCRC5AR1NPY2R
SCHEMBL31174210 0.89 MC4R (0.60) MC4RRAMP3CALCRF2C5AR1
SCHEMBL31182654 0.89 NPY2R (0.66) RAMP3CALCRC5AR1NPY2RNPY4R
SCHEMBL31182616 0.89 RAMP3 (0.63) RAMP3CALCRF2NPY2RNPY4R
SCHEMBL30432646 0.89 CALCR (0.67) CALCRF2C5AR1NPY2RNPY4R
SCHEMBL30607329 0.89 F2 (0.68) RAMP3CALCRF2C5AR1NMUR2
SCHEMBL30726629 0.88 F2 (0.63) MC4RCALCRF2C5AR1NPY2R
SCHEMBL29742947 0.88 F2 (0.62) MC4RCALCRF2C5AR1NPY2R
SCHEMBL30576961 0.88 RAMP3 (0.59) RAMP3CALCRC5AR1APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230040544-A1 COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC) SAREPTA THERAPEUTICS, INC. 2023-02-09 — — US disclosed
Send feedback